Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs Pieverse (PIEVERSE) Price & Performance

Bio ProtocolTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs Pieverse — how do they compare? Bio Protocol trades at Rp440.95 (market cap Rp997,34M, Rp163,74M 24h volume), while Pieverse trades at Rp13,949 (market cap Rp3,79T, Rp119,29M 24h volume). The key difference: Pieverse is far larger — about 3800.1× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 270,6M / 1B PIEVERSE (28%) for Pieverse. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Pieverse for 5 Days on average.

BIOPIEVERSE
Market Cap
Rp997,34MRp3,79T
Volume (24h)
Rp163,74MRp119,29M
Circulating Supply
2,3B / 3,3B BIO (69%)270,6M / 1B PIEVERSE (28%)
Typical Hold Time
18 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio Protocol

Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.

Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.

Pieverse

Pieverse is trading at Rp14,098 with a market cap of Rp3.78T, showing a bullish technical signal from moving averages while oscillators remain neutral. The asset trades above its pivot point of Rp13,526, with immediate resistance at Rp14,121. With a circulating supply of 270.6 million tokens (28% of max supply) and an average hold time of 5 days, the token demonstrates moderate circulation activity.

Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include potential breakout above resistance levels, while risks involve low liquidity and absence of recent ecosystem developments. Investors should monitor volume patterns and any protocol updates closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
97% Buy3% Sell
Avg holding period · 18 Days
PIEVERSE
53% Buy47% Sell
Avg holding period · 5 Days

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About Pieverse

Pieverse is an agent-native payment infrastructure for Web3, designed to make on-chain transactions verifiable, auditable, and compliant. Built on x402b rails, it timestamps value through on-chain invoices, receipts, and checks. This enables seamless payments that link blockchain activity to real-world requirements, such as tax reporting and financial audits.

Read more on PIEVERSE